News/ News/ R&D Data backs AZ’s Wilson disease drug, but with a question mark Phil Taylor Alexion, AstraZeneca, rare disease, Wilson disease 0 Comment Last year, AstraZeneca reported that a new drug to treat Wilson disease developed by its Alexion rare diseases Share X Data backs AZ’s Wilson disease drug, but with a question mark https://pharmaphorum.com/news/data-backs-azs-wilson-disease-drug-but-with-a-question-mark/
News/ News/ R&D After Ultomiris stumble, Alexion delivers a rare disease win for AZ Phil Taylor Alexion, AstraZeneca, rare disease, Wilson disease 0 Comment A drug for Wilson disease developed by AstraZeneca’s Alexion rare disease unit has cleared a phase 3 trial, Share X After Ultomiris stumble, Alexion delivers a rare disease win for AZ https://pharmaphorum.com/news/after-ultomiris-stumble-alexion-delivers-a-rare-disease-win-for-az/
Alexion, AstraZeneca, rare disease, Wilson disease
0 Comment
